Developing Growth Fund
Daily price w/o sales charge as of 11/07/2024
$23.73
$0.10
YTD Returns w/o sales charge as of 11/07/2024
29.04%
Please click here for performance current to the most recent quarter-end and month-end.
Summary
Summary
Fund Basicsas of 09/30/2024
- Total Net Assets
- $2.52 B
- Inception Date
- 10/10/1973
- Dividend Frequency
- Annually
- Fund Gross Expense Ratio
- 0.92%
- Fund Net Expense Ratio
- 0.92%
- Number of Holdings
- 77
- Minimum Initial Investment
- $1,000+
Fund Expense Ratio :
Gross 0.92%
Net 0.92%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 10/10/1973 |
|---|
| w/o sales charge | 19.68% | 45.86% | -8.76% | 7.94% | 8.50% | 10.46% |
| Lipper Category Avg. Small-Cap Growth Funds | 11.71% | 34.18% | -3.50% | 8.99% | 9.12% | - |
| Russell 2000® Growth Index | 11.72% | 36.49% | -2.30% | 7.92% | 8.15% | - |
| w/ sales charge | 12.81% | 37.48% | -10.54% | 6.68% | 7.86% | 10.33% |
Fund Expense Ratio :
Gross 0.92%
Net 0.92%
Fund Expense Ratio :
Gross 0.92%
Net 0.92%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 10/10/1973 |
|---|
| w/o sales charge | 20.83% | 34.67% | -6.79% | 8.61% | 9.23% | 10.50% |
| Lipper Category Avg. Small-Cap Growth Funds | 13.34% | 26.11% | -1.27% | 9.68% | 9.84% | - |
| Russell 2000® Growth Index | 13.22% | 27.66% | -0.35% | 8.82% | 8.95% | - |
| w/ sales charge | 13.89% | 26.90% | -8.62% | 7.34% | 8.58% | 10.37% |
Fund Expense Ratio :
Gross 0.92%
Net 0.92%
Returns with sales charges reflect a maximum sales charge of 5.75%.
The performance quoted represents past performance, which is no indication of future results. Current performance may be higher or lower than the performance data quoted. Returns shown include the reinvestment of all distributions. Returns shown at net asset value do not reflect the current maximum sales charge, had the sales charge been included, returns would have been lower. The investment return and principal value of an investment will fluctuate so that shares, on any given day or when redeemed, may be worth more or less than the original cost. Therefore, there can be no assurance for future results.
TEN LARGEST HOLDINGS as of 09/30/2024View Portfolio
| Holding | Assets |
|---|---|
| Cava Group Inc | 2.2% |
| CyberArk Software Ltd | 2.2% |
| Zeta Global Holdings Corp | 2.1% |
| Glaukos Corp | 2.1% |
| Piper Sandler Cos | 2.1% |
| TransMedics Group Inc | 2.0% |
| Sweetgreen Inc | 1.9% |
| Varonis Systems Inc | 1.9% |
| ADMA Biologics Inc | 1.9% |
| Comfort Systems USA Inc | 1.9% |
Aggregate holdings are updated monthly, 30 days after month end. Aggregate holdings are presented to illustrate examples of the securities that the Fund has bought and the diversity of the areas in which the Fund may invest, and may not be representative of the Fund's current or future investments. The figures presented are as of the date shown and may change at any time.
Sector Allocationas of 09/30/2024View Portfolio
| Sector | Weighting |
|---|
| Sector | Weighting |
|---|---|
| Communication Services | |
| Real Estate | |
| Utilities | |
| Consumer Discretionary | |
| Consumer Staples | |
| Energy | |
| Financials | |
| Health Care | |
| Industrials | |
| Information Technology | |
| Materials |
INVESTMENT TEAM
Your Representative
To contact your representative, enter your zip code and select your channel below.
Performance
Performance
Fund Expense Ratio :
Gross 0.92%
Net 0.92%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 10/10/1973 |
|---|
| w/o sales charge | 19.68% | 45.86% | -8.76% | 7.94% | 8.50% | 10.46% |
| Lipper Category Avg. Small-Cap Growth Funds | 11.71% | 34.18% | -3.50% | 8.99% | 9.12% | - |
| Russell 2000® Growth Index | 11.72% | 36.49% | -2.30% | 7.92% | 8.15% | - |
| w/ sales charge | 12.81% | 37.48% | -10.54% | 6.68% | 7.86% | 10.33% |
Fund Expense Ratio :
Gross 0.92%
Net 0.92%
Fund Expense Ratio :
Gross 0.92%
Net 0.92%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 10/10/1973 |
|---|
| w/o sales charge | 20.83% | 34.67% | -6.79% | 8.61% | 9.23% | 10.50% |
| Lipper Category Avg. Small-Cap Growth Funds | 13.34% | 26.11% | -1.27% | 9.68% | 9.84% | - |
| Russell 2000® Growth Index | 13.22% | 27.66% | -0.35% | 8.82% | 8.95% | - |
| w/ sales charge | 13.89% | 26.90% | -8.62% | 7.34% | 8.58% | 10.37% |
Fund Expense Ratio :
Gross 0.92%
Net 0.92%
Returns with sales charges reflect a maximum sales charge of 5.75%.
The performance quoted represents past performance, which is no indication of future results. Current performance may be higher or lower than the performance data quoted. Returns shown include the reinvestment of all distributions. Returns shown at net asset value do not reflect the current maximum sales charge, had the sales charge been included, returns would have been lower. The investment return and principal value of an investment will fluctuate so that shares, on any given day or when redeemed, may be worth more or less than the original cost. Therefore, there can be no assurance for future results.
| Year | Fund Returns | Russell 2000® Growth Index |
|---|
| 2023 | 8.50% | 18.66% |
| 2022 | -36.09% | -26.36% |
| 2021 | -2.66% | 2.83% |
| 2020 | 72.57% | 34.63% |
| 2019 | 31.91% | 28.48% |
| 2018 | 5.09% | -9.31% |
| 2017 | 29.92% | 22.17% |
| 2016 | -2.71% | 11.32% |
| 2015 | -8.90% | -1.38% |
| 2014 | 3.25% | 5.60% |
| 2013 | 57.19% | - |
| 2012 | 10.39% | - |
| 2011 | -1.66% | - |
| 2010 | 36.54% | - |
| 2009 | 47.03% | - |
| 2008 | -47.50% | - |
| 2007 | 35.83% | - |
| 2006 | 12.45% | - |
| 2005 | 11.87% | - |
| 2004 | 6.00% | - |
| Year | Q1 | Q2 | Q3 | Q4 |
|---|
| 2024 | 12.62% | 0.92% | 6.32% | - |
| 2023 | 8.32% | 3.27% | -12.97% | 11.45% |
| 2022 | -19.27% | -21.16% | 0.59% | -0.18% |
| 2021 | 1.64% | 2.87% | -3.66% | -3.35% |
| 2020 | -16.91% | 40.59% | 15.92% | 27.45% |
| 2019 | 27.01% | 9.09% | -11.35% | 7.39% |
| 2018 | 7.16% | 14.97% | 12.18% | -23.96% |
| 2017 | 8.36% | 4.06% | 7.07% | 7.61% |
| 2016 | -10.30% | 2.24% | 10.87% | -4.32% |
| 2015 | 7.12% | 2.61% | -15.70% | -1.68% |
| 2014 | 1.67% | 0.15% | -5.75% | 7.59% |
| 2013 | 13.50% | 10.00% | 18.78% | 6.00% |
| 2012 | 12.16% | -2.68% | 5.55% | -4.19% |
| 2011 | 10.23% | 1.49% | -20.86% | 11.06% |
| 2010 | 8.21% | -7.94% | 16.47% | 17.68% |
| 2009 | -2.17% | 24.37% | 14.25% | 5.76% |
| 2008 | -21.82% | 6.65% | -11.81% | -28.60% |
| 2007 | 4.65% | 13.60% | 9.82% | 4.04% |
| 2006 | 15.98% | -6.23% | -6.80% | 10.93% |
| 2005 | -5.91% | 5.82% | 9.60% | 2.52% |
| 2004 | 2.00% | 0.20% | -7.05% | 11.58% |
| 2003 | -3.27% | 21.33% | 9.79% | 8.70% |
| 2002 | 0.07% | -11.90% | -23.81% | 4.90% |
| 2001 | -17.44% | 16.01% | -22.68% | 25.62% |
| 2000 | 3.52% | -13.67% | -0.56% | -7.37% |
| 1999 | 1.42% | 11.69% | -3.37% | 26.23% |
| 1998 | 11.49% | -2.94% | -22.00% | 28.29% |
| 1997 | -2.88% | 17.68% | 21.77% | -6.03% |
| 1996 | 8.18% | 8.18% | -2.85% | 7.46% |
| 1995 | 6.04% | 19.02% | 15.90% | -0.42% |
| 1994 | 0.16% | -8.07% | 10.54% | 4.34% |
| 1993 | -0.67% | 1.03% | 8.15% | 3.76% |
| 1992 | -2.92% | -13.34% | 5.39% | 9.32% |
| 1991 | 29.96% | -5.07% | 9.77% | 15.46% |
| 1990 | 1.18% | 11.38% | -24.62% | 10.17% |
| 1989 | 3.04% | 1.70% | 8.07% | 0.77% |
| 1988 | 8.71% | 2.49% | -4.04% | -3.23% |
| 1987 | 23.22% | -1.54% | 5.33% | -21.15% |
| 1986 | 12.02% | 1.82% | -18.44% | 7.95% |
| 1985 | 9.91% | -2.42% | -9.28% | 18.16% |
| 1984 | -15.56% | -5.27% | 1.63% | -4.54% |
| 1983 | 19.37% | 16.69% | -4.44% | -6.33% |
| 1982 | -11.29% | 1.28% | 11.66% | 29.18% |
| 1981 | 6.38% | 7.72% | -18.09% | 14.79% |
| 1980 | -8.32% | 13.37% | 24.22% | 5.17% |
| 1979 | 11.23% | 3.38% | 10.21% | 1.23% |
| 1978 | 12.74% | 18.50% | 11.85% | -9.31% |
| 1977 | -5.21% | 6.36% | 3.99% | 7.90% |
| 1976 | 25.90% | -5.36% | -5.21% | 5.87% |
| 1975 | 36.09% | 17.79% | -12.76% | -0.65% |
| 1974 | 2.02% | -14.31% | -23.96% | -3.25% |
Performance is shown for each quarter and each calendar year. Past performance is no guarantee of future results.
Growth of $10,000 as of 10/31/2024
The chart begins on the Fund's inception date of 10/10/1973.
Based on a hypothetical Class A share investment of $10,000 on 10/10/1973 without sales charge and includes the reinvestment of all distributions.
NAV Historical Prices
| Date | Net Asset Value |
|---|
Portfolio
Portfolio
| Holding | Sector | Assets |
|---|
| Cava Group Inc | Consumer Discretionary | 2.2% |
| CyberArk Software Ltd | Information Technology | 2.2% |
| Zeta Global Holdings Corp | Information Technology | 2.1% |
| Glaukos Corp | Health Care | 2.1% |
| Piper Sandler Cos | Financials | 2.1% |
| TransMedics Group Inc | Health Care | 2.0% |
| Sweetgreen Inc | Consumer Discretionary | 1.9% |
| Varonis Systems Inc | Information Technology | 1.9% |
| ADMA Biologics Inc | Health Care | 1.9% |
| Comfort Systems USA Inc | Industrials | 1.9% |
Aggregate holdings are updated monthly, 30 days after month end. Aggregate holdings are presented to illustrate examples of the securities that the Fund has bought and the diversity of the areas in which the Fund may invest, and may not be representative of the Fund's current or future investments. The figures presented are as of the date shown and may change at any time.
| Holding | Sector | Assets |
|---|
| Cava Group Inc | Consumer Discretionary | 2.2% |
| CyberArk Software Ltd | Information Technology | 2.2% |
| Zeta Global Holdings Corp | Information Technology | 2.1% |
| Glaukos Corp | Health Care | 2.1% |
| Piper Sandler Cos | Financials | 2.1% |
| TransMedics Group Inc | Health Care | 2.0% |
| Sweetgreen Inc | Consumer Discretionary | 1.9% |
| Varonis Systems Inc | Information Technology | 1.9% |
| ADMA Biologics Inc | Health Care | 1.9% |
| Comfort Systems USA Inc | Industrials | 1.9% |
| Agilysys Inc | Information Technology | 1.8% |
| Appfolio Inc | Information Technology | 1.8% |
| FTAI Aviation Ltd | Industrials | 1.8% |
| Loar Holdings Inc | Industrials | 1.8% |
| Hamilton Lane Inc | Financials | 1.7% |
| Freshpet Inc | Consumer Staples | 1.7% |
| Guidewire Software Inc | Information Technology | 1.7% |
| Blueprint Medicines Corp | Health Care | 1.6% |
| Parsons Corp | Industrials | 1.6% |
| Insmed Inc | Health Care | 1.6% |
| Crane Co | Industrials | 1.6% |
| Modine Manufacturing Co | Consumer Discretionary | 1.6% |
| Evercore Inc | Financials | 1.5% |
| SPS Commerce Inc | Information Technology | 1.5% |
| Arcellx Inc | Health Care | 1.5% |
| Natera Inc | Health Care | 1.5% |
| MakeMyTrip Ltd | Consumer Discretionary | 1.5% |
| AeroVironment Inc | Industrials | 1.4% |
| Onto Innovation Inc | Information Technology | 1.4% |
| Intra-Cellular Therapies Inc | Health Care | 1.4% |
| Impinj Inc | Information Technology | 1.4% |
| Wix.com Ltd | Information Technology | 1.4% |
| Wingstop Inc | Consumer Discretionary | 1.4% |
| Monday.com Ltd | Information Technology | 1.4% |
| Credo Technology Group Holding Ltd | Information Technology | 1.4% |
| Krystal Biotech Inc | Health Care | 1.3% |
| Itron Inc | Information Technology | 1.3% |
| Sterling Infrastructure Inc | Industrials | 1.3% |
| Lantheus Holdings Inc | Health Care | 1.3% |
| Bright Horizons Family Solutions Inc | Consumer Discretionary | 1.2% |
| Stride Inc | Consumer Discretionary | 1.2% |
| Reddit Inc | Communication Services | 1.2% |
| PROCEPT BioRobotics Corp | Health Care | 1.1% |
| RxSight Inc | Health Care | 1.1% |
| SPX Technologies Inc | Industrials | 1.1% |
| Merus NV | Health Care | 1.1% |
| Vaxcyte Inc | Health Care | 1.1% |
| Vertex Inc | Information Technology | 1.1% |
| Descartes Systems Group Inc/The | Information Technology | 1.1% |
| Sprouts Farmers Market Inc | Consumer Staples | 1.0% |
| Moog Inc | Industrials | 1.0% |
| Nova Ltd | Information Technology | 1.0% |
| Verra Mobility Corp | Industrials | 1.0% |
| Life Time Group Holdings Inc | Consumer Discretionary | 1.0% |
| Nuvalent Inc | Health Care | 1.0% |
| Camtek Ltd/Israel | Information Technology | 1.0% |
| AAON Inc | Industrials | 1.0% |
| SpringWorks Therapeutics Inc | Health Care | 0.9% |
| REVOLUTION Medicines Inc | Health Care | 0.9% |
| Tetra Tech Inc | Industrials | 0.9% |
| Doximity Inc | Health Care | 0.9% |
| Fabrinet | Information Technology | 0.9% |
| Baldwin Insurance Group Inc/The | Financials | 0.9% |
| Maplebear Inc | Consumer Staples | 0.9% |
| Crinetics Pharmaceuticals Inc | Health Care | 0.9% |
| Duolingo Inc | Consumer Discretionary | 0.8% |
| Q2 Holdings Inc | Information Technology | 0.8% |
| Primo Water Corp | Consumer Staples | 0.8% |
| Avidity Biosciences Inc | Health Care | 0.8% |
| Ollie's Bargain Outlet Holdings Inc | Consumer Discretionary | 0.7% |
| Astera Labs Inc | Information Technology | 0.7% |
| Janux Therapeutics Inc | Health Care | 0.7% |
| Criteo SA | Communication Services | 0.6% |
| Clear Secure Inc | Information Technology | 0.6% |
| Mirum Pharmaceuticals Inc | Health Care | 0.5% |
| Meritage Homes Corp | Consumer Discretionary | 0.5% |
| Guardant Health Inc | Health Care | 0.5% |
Aggregate holdings are updated monthly, 30 days after month end. Aggregate holdings are presented to illustrate examples of the securities that the Fund has bought and the diversity of the areas in which the Fund may invest, and may not be representative of the Fund's current or future investments. The figures presented are as of the date shown and may change at any time.
Sector Allocationas of 09/30/2024
| Sector | Weighting | Fund Change from Previous Quarter |
|---|
| Sector | Weighting | Fund Change from Previous Quarter |
|---|---|---|
| Communication Services |
1.8%
|
|
| Real Estate | 0.0% | |
| Utilities | 0.0% | |
| Consumer Discretionary |
0.3%
|
|
| Consumer Staples |
 2.8%
|
|
| Energy | 0.0% | |
| Financials |
1.0%
|
|
| Health Care |
6.3%
|
|
| Industrials |
5.4%
|
|
| Information Technology | 0.0% | |
| Materials | 0.0% |
Dividends & Cap Gains
Dividends & Cap Gains
Dividend Payments
- YTD Dividends Paidas of 11/07/2024
- $0
- Dividend Frequency
- Annually
| Record Date | Ex-Dividend Date | Reinvest & Payable Date | Dividend | Reinvest Price |
|---|---|---|---|---|
| 02/14/1997 | 02/18/1997 | 03/03/1997 | $0.00000 |
Upcoming Dividend Payment Dates
This section lists all anticipated Income and Capital Gain distribution dates and any actual distributions are subject to adequacy of earnings and must be approved by the Board of Directors/Trustees. Please note that dates are subject to change.
| Record Date | Ex-Dividend Date | Reinvest & Payable Date |
|---|---|---|
| 11/25/2024 | 11/26/2024 | 11/26/2024 |
Capital Gains Distributions
| Record Date | Reinvest & Payable Date | Long-term | Short-term * | Total | Reinvest Price |
|---|---|---|---|---|---|
| 11/22/2021 | 11/23/2021 | $3.3406 | - | $3.3406 | $27.44 |
Taxed as ordinary income
Lord Abbett does not provide tax advice. It is strongly recommended that you discuss the impact of dividends and distributions with your tax advisor.
Fees & Expenses
Fees & Expenses
Sales Charge Schedule as of 11/07/2024
| Sales Charge | Dealer's Concession | Prices at Breakpoint | |
|---|---|---|---|
| Less than $50,000 | 5.75% | 5.00% | $25.18 |
| $50,000 to $99,999 | 4.75% | 4.00% | $24.91 |
| $100,000 to $249,999 | 3.95% | 3.25% | $24.71 |
| $250,000 to $499,999 | 2.75% | 2.25% | $24.40 |
| $500,000 to $999,999 | 1.95% | 1.75% | $24.20 |
| $1,000,000 to $5,000,000 | 0.00% | 1.00% | $23.73 |
The 12b-1 trail commission is 0.15% (accrues immediately) for all fixed-income and municipal income funds.
Class A shares purchased without a sales charge (commissionable NAV) will be subject to a CDSC of 1% if they are redeemed before the first day of the month in which the one-year anniversary of the purchase falls.
Expense Ratioas of 10/31/2024
| Fund Gross Expense Ratio | 0.92% |
| Fund Net Expense Ratio | 0.92% |
| Adjusted Expense Ratio | - |
Fund Documents
Fund Documents
|
0Documents selected
|
||||
|---|---|---|---|---|
|
Portfolio Holdings 1Q
Publish Date:11/03/2015
|
||||
|
Portfolio Holdings 3Q
Publish Date:11/03/2015
|
||||
|
Summary Prospectus
Publish Date:11/03/2015
|
||||
|
Statutory Prospectus
Publish Date:11/03/2015
|
||||
|
SAI
Publish Date:11/03/2015
|
||||
|
Annual Financial Statements and Other Information *
Publish Date:11/03/2015
|
||||
|
Annual Tailored Shareholder Report
Publish Date:11/03/2015
|
||||
|
Semi-Annual Financial Statements and Other Information *
Publish Date:11/03/2015
|
||||
|
Fact Sheet
Publish Date:11/03/2015
|
||||
|
Commentary
Publish Date:11/03/2015
|
||||
|
Fund Story
Publish Date:11/03/2015
|